{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:28:20Z","timestamp":1791296900461,"version":"4.1.0"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"abstract":"<jats:p>OBJECTIVE. In addition to the core behavioral symptoms of autism spectrum disorder, many patients present with complex medical conditions including gastrointestinal dysfunction. A functional variant in the promoter of the gene encoding the MET receptor tyrosine kinase is associated with autism spectrum disorder, and MET protein expression is decreased in the temporal cortex of subjects with autism spectrum disorder. MET is a pleiotropic receptor that functions in both brain development and gastrointestinal repair. On the basis of these functions, we hypothesized that association of the autism spectrum disorder\u2013associated MET promoter variant may be enriched in a subset of individuals with co-occurring autism spectrum disorder and gastrointestinal conditions.<\/jats:p>\n               <jats:p>PATIENTS AND METHODS. Subjects were 918 individuals from 214 Autism Genetics Resource Exchange families with a complete medical history including gastrointestinal condition report. Genotypes at the autism spectrum disorder\u2013associated MET promoter variant rs1858830 were determined. Family-based association test and \u03c72 analyses were used to determine the association of MET rs1858830 alleles with autism spectrum disorder and the presence of gastrointestinal conditions.<\/jats:p>\n               <jats:p>RESULTS. In the entire 214-family sample, the MET rs1858830 C allele was associated with both autism spectrum disorder and gastrointestinal conditions. Stratification by the presence of gastrointestinal conditions revealed that the MET C allele was associated with both autism spectrum disorder and gastrointestinal conditions in 118 families containing at least 1 child with co-occurring autism spectrum disorder and gastrointestinal conditions. In contrast, there was no association of the MET polymorphism with autism spectrum disorder in the 96 families lacking a child with co-occurring autism spectrum disorder and gastrointestinal conditions. \u03c72 analyses of MET rs1858830 genotypes indicated over-representation of the C allele in individuals with co-occurring autism spectrum disorder and gastrointestinal conditions compared with non-autism spectrum disorder siblings, parents, and unrelated controls.<\/jats:p>\n               <jats:p>CONCLUSION. These results suggest that disrupted MET signaling may contribute to increased risk for autism spectrum disorder that includes familial gastrointestinal dysfunction.<\/jats:p>","DOI":"10.1542\/peds.2008-0819","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T12:49:02Z","timestamp":1235998142000},"page":"1018-1024","source":"Crossref","is-referenced-by-count":129,"title":["Distinct Genetic Risk Based on Association of <i>MET<\/i> in Families With Co-occurring Autism and Gastrointestinal Conditions"],"prefix":"10.1542","volume":"123","author":[{"given":"Daniel B.","family":"Campbell","sequence":"first","affiliation":[{"name":"Department of Pharmacology"},{"name":"Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Buie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Pediatric Gastroenterology, Mass General Hospital for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harland","family":"Winter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Pediatric Gastroenterology, Mass General Hospital for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Bauman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Pediatric Gastroenterology, Mass General Hospital for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Sutcliffe","sequence":"additional","affiliation":[{"name":"Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee"},{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Perrin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Pediatric Gastroenterology, Mass General Hospital for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Levitt","sequence":"additional","affiliation":[{"name":"Department of Pharmacology"},{"name":"Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,3,1]]},"reference":[{"key":"2021120902514472900_R1","doi-asserted-by":"crossref","unstructured":"Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr.\u20081999;135(5):559\u2013563","DOI":"10.1016\/S0022-3476(99)70052-1"},{"key":"2021120902514472900_R2","doi-asserted-by":"crossref","unstructured":"Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr.\u20082006;27(suppl 2):S128\u2013S136","DOI":"10.1097\/00004703-200604002-00011"},{"key":"2021120902514472900_R3","doi-asserted-by":"crossref","unstructured":"Levy SE, Souders MC, Ittenbach RF, Giarelli E, Mulberg AE, Pinto-Martin JA. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry.\u20082007;61(4):492\u2013497","DOI":"10.1016\/j.biopsych.2006.07.013"},{"key":"2021120902514472900_R4","doi-asserted-by":"crossref","unstructured":"Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry.\u20082005;17(6):485\u2013495","DOI":"10.1080\/02646830500381930"},{"key":"2021120902514472900_R5","doi-asserted-by":"crossref","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol.\u20082005;57(1):67\u201381","DOI":"10.1002\/ana.20315"},{"key":"2021120902514472900_R6","doi-asserted-by":"crossref","unstructured":"Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol.\u20082007;17(1):103\u2013111","DOI":"10.1016\/j.conb.2007.01.009"},{"key":"2021120902514472900_R7","doi-asserted-by":"crossref","unstructured":"Quigley EM, Hurley D. Autism and the gastrointestinal tract. Am J Gastroenterol.\u20082000;95(9):2154\u20132156","DOI":"10.1111\/j.1572-0241.2000.03247.x"},{"key":"2021120902514472900_R8","doi-asserted-by":"crossref","unstructured":"Molloy CA, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism.\u20082003;7(2):165\u2013171","DOI":"10.1177\/1362361303007002004"},{"key":"2021120902514472900_R9","doi-asserted-by":"crossref","unstructured":"Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ. Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord.\u20082005;35(6):713\u2013727","DOI":"10.1007\/s10803-005-0019-4"},{"key":"2021120902514472900_R10","doi-asserted-by":"crossref","unstructured":"Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ.\u20082002;325(7361):419\u2013421","DOI":"10.1136\/bmj.325.7361.419"},{"key":"2021120902514472900_R11","doi-asserted-by":"crossref","unstructured":"Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci.\u20082006;29(7):349\u2013358","DOI":"10.1016\/j.tins.2006.05.010"},{"key":"2021120902514472900_R12","doi-asserted-by":"crossref","unstructured":"Gupta AR, State MW. Recent advances in the genetics of autism. Biol Psychiatry.\u20082007;61(4):429\u2013437","DOI":"10.1016\/j.biopsych.2006.06.020"},{"key":"2021120902514472900_R13","doi-asserted-by":"crossref","unstructured":"Yang MS, Gill M. A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int J Dev Neurosci.\u20082007;25(2):69\u201385","DOI":"10.1016\/j.ijdevneu.2006.12.002"},{"key":"2021120902514472900_R14","doi-asserted-by":"crossref","unstructured":"Campbell DB, Sutcliffe JS, Ebert PJ, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA.\u20082006;103(45):16834\u201316839","DOI":"10.1073\/pnas.0605296103"},{"key":"2021120902514472900_R15","doi-asserted-by":"crossref","unstructured":"Campbell DB, D'Oronzio R, Garbett K, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol.\u20082007;62(3):243\u2013250","DOI":"10.1002\/ana.21180"},{"key":"2021120902514472900_R16","doi-asserted-by":"crossref","unstructured":"Ieraci A, Forni PE, Ponzetto C. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci USA.\u20082002;99(23):15200\u201315205","DOI":"10.1073\/pnas.222362099"},{"key":"2021120902514472900_R17","doi-asserted-by":"crossref","unstructured":"Levitt P. Disruption of interneuron development. Epilepsia.\u20082005;46(suppl 7):22\u201328","DOI":"10.1111\/j.1528-1167.2005.00305.x"},{"key":"2021120902514472900_R18","doi-asserted-by":"crossref","unstructured":"Powell EM, Mars WM, Levitt P. Hepatocyte growth factor\/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron.\u20082001;30(1):79\u201389","DOI":"10.1016\/S0896-6273(01)00264-1"},{"key":"2021120902514472900_R19","doi-asserted-by":"crossref","unstructured":"Powell EM, Campbell DB, Stanwood GD, et al. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci.\u20082003;23(2):622\u2013631","DOI":"10.1523\/JNEUROSCI.23-02-00622.2003"},{"key":"2021120902514472900_R20","doi-asserted-by":"crossref","unstructured":"Gutierrez H, Dolcet X, Tolcos M, Davies A. HGF regulates the development of cortical pyramidal dendrites. Development.\u20082004;131(15):3717\u20133726","DOI":"10.1242\/dev.01209"},{"key":"2021120902514472900_R21","doi-asserted-by":"crossref","unstructured":"Tyndall SJ, Walikonis RS. The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle.\u20082006;5(14):1560\u20131568","DOI":"10.4161\/cc.5.14.2918"},{"key":"2021120902514472900_R22","doi-asserted-by":"crossref","unstructured":"Tyndall SJ, Walikonis RS. Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity. Synapse.\u20082007;61(4):199\u2013204","DOI":"10.1002\/syn.20362"},{"key":"2021120902514472900_R23","doi-asserted-by":"crossref","unstructured":"Beilmann M, Odenthal M, Jung W, Vande Woude GF, Dienes HP, Schirmacher P. Neoexpression of the c-met\/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood.\u20081997;90(11):4450\u20134458","DOI":"10.1182\/blood.V90.11.4450.4450_4450_4458"},{"key":"2021120902514472900_R24","doi-asserted-by":"crossref","unstructured":"Beilmann M, Vande Woude GF, Dienes HP, Schirmacher P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood.\u20082000;95(12):3964\u20133969","DOI":"10.1182\/blood.V95.12.3964"},{"key":"2021120902514472900_R25","doi-asserted-by":"crossref","unstructured":"Okunishi K, Dohi M, Nakagome K, et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol.\u20082005;175(7):4745\u20134753","DOI":"10.4049\/jimmunol.175.7.4745"},{"key":"2021120902514472900_R26","doi-asserted-by":"crossref","unstructured":"Tahara Y, Ido A, Yamamoto S, et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther.\u20082003;307(1):146\u2013151","DOI":"10.1124\/jpet.103.054106"},{"key":"2021120902514472900_R27","doi-asserted-by":"crossref","unstructured":"Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J Pediatr Surg.\u20082004;39(2):139\u2013143","DOI":"10.1016\/j.jpedsurg.2003.10.001"},{"key":"2021120902514472900_R28","doi-asserted-by":"crossref","unstructured":"Ido A, Numata M, Kodama M, Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol.\u20082005;40(10):925\u2013931","DOI":"10.1007\/s00535-005-1705-x"},{"key":"2021120902514472900_R29","doi-asserted-by":"crossref","unstructured":"Eagleson KL, Bonnin A, Levitt P. Region- and age-specific deficits in gamma-aminobutyric acidergic neuron development in the telencephalon of the uPAR(\u2212\/\u2212) mouse. J Comp Neurol.\u20082005;489(4):449\u2013466","DOI":"10.1002\/cne.20647"},{"key":"2021120902514472900_R30","doi-asserted-by":"crossref","unstructured":"Akimoto M, Baba A, Ikeda-Matsuo Y, et al. Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience.\u20082004;128(1):155\u2013162","DOI":"10.1016\/j.neuroscience.2004.06.031"},{"key":"2021120902514472900_R31","doi-asserted-by":"crossref","unstructured":"Arthur LG, Kuenzler KA, Schwartz MZ. Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model. J Gastrointest Surg.\u20082003;7(8):1062\u20131068","DOI":"10.1016\/j.gassur.2003.09.014"},{"key":"2021120902514472900_R32","doi-asserted-by":"crossref","unstructured":"Hanawa T, Suzuki K, Kawauchi Y, et al. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver. J Gene Med.\u20082006;8(5):623\u2013635","DOI":"10.1002\/jgm.880"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/3\/1018\/1067706\/zpe00309001018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/3\/1018\/1067706\/zpe00309001018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T16:07:12Z","timestamp":1639066032000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/3\/1018\/71762\/Distinct-Genetic-Risk-Based-on-Association-of-MET"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,1]]},"published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-0819","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,1]]}}}